33685483|t|Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
33685483|a|BACKGROUND: Emerging evidence indicates that impaired mitophagy-mediated clearance of defective mitochondria is a critical event in Alzheimer's disease (AD) pathogenesis. Amyloid-beta (Abeta) metabolism and the microtubule-associated protein tau have been reported to regulate key components of the mitophagy machinery. However, the mechanisms that lead to mitophagy dysfunction in AD are not fully deciphered. We have previously shown that intraneuronal cholesterol accumulation can disrupt the autophagy flux, resulting in low Abeta clearance. In this study, we examine the impact of neuronal cholesterol changes on mitochondrial removal by autophagy. METHODS: Regulation of PINK1-parkin-mediated mitophagy was investigated in conditions of acute (in vitro) and chronic (in vivo) high cholesterol loading using cholesterol-enriched SH-SY5Y cells, cultured primary neurons from transgenic mice overexpressing active SREBF2 (sterol regulatory element binding factor 2), and mice of increasing age that express the amyloid precursor protein with the familial Alzheimer Swedish mutation (Mo/HuAPP695swe) and mutant presenilin 1 (PS1-dE9) together with active SREBF2. RESULTS: In cholesterol-enriched SH-SY5Y cells and cultured primary neurons, high intracellular cholesterol levels stimulated mitochondrial PINK1 accumulation and mitophagosomes formation triggered by Abeta while impairing lysosomal-mediated clearance. Antioxidant recovery of cholesterol-induced mitochondrial glutathione (GSH) depletion prevented mitophagosomes formation indicating mitochondrial ROS involvement. Interestingly, when brain cholesterol accumulated chronically in aged APP-PSEN1-SREBF2 mice the mitophagy flux was affected at the early steps of the pathway, with defective recruitment of the key autophagy receptor optineurin (OPTN). Sustained cholesterol-induced alterations in APP-PSEN1-SREBF2 mice promoted an age-dependent accumulation of OPTN into HDAC6-positive aggresomes, which disappeared after in vivo treatment with GSH ethyl ester (GSHee). The analyses in post-mortem brain tissues from individuals with AD confirmed these findings, showing OPTN in aggresome-like structures that correlated with high mitochondrial cholesterol levels in late AD stages. CONCLUSIONS: Our data demonstrate that accumulation of intracellular cholesterol reduces the clearance of defective mitochondria and suggest recovery of the cholesterol homeostasis and the mitochondrial scavenging of ROS as potential therapeutic targets for AD.
33685483	0	11	Cholesterol	Chemical	MESH:D002784
33685483	42	52	optineurin	Gene	71648
33685483	92	111	Alzheimer's disease	Disease	MESH:D000544
33685483	245	264	Alzheimer's disease	Disease	MESH:D000544
33685483	266	268	AD	Disease	MESH:D000544
33685483	284	296	Amyloid-beta	Gene	351
33685483	298	303	Abeta	Gene	351
33685483	324	354	microtubule-associated protein	Gene	66302
33685483	495	497	AD	Disease	MESH:D000544
33685483	568	579	cholesterol	Chemical	MESH:D002784
33685483	642	647	Abeta	Gene	351
33685483	708	719	cholesterol	Chemical	MESH:D002784
33685483	790	795	PINK1	Gene	65018
33685483	796	802	parkin	Gene	5071
33685483	900	911	cholesterol	Chemical	MESH:D002784
33685483	926	937	cholesterol	Chemical	MESH:D002784
33685483	947	954	SH-SY5Y	CellLine	CVCL:0019
33685483	1003	1007	mice	Species	10090
33685483	1030	1036	SREBF2	Gene	20788
33685483	1038	1080	sterol regulatory element binding factor 2	Gene	20788
33685483	1087	1091	mice	Species	10090
33685483	1127	1152	amyloid precursor protein	Gene	11820
33685483	1162	1188	familial Alzheimer Swedish	Disease	MESH:D000544
33685483	1199	1201	Mo	CellLine	CVCL:1439
33685483	1202	1213	HuAPP695swe	CellLine	CVCL:D650
33685483	1226	1238	presenilin 1	Gene	19164
33685483	1270	1276	SREBF2	Gene	20788
33685483	1290	1301	cholesterol	Chemical	MESH:D002784
33685483	1311	1318	SH-SY5Y	CellLine	CVCL:0019
33685483	1374	1385	cholesterol	Chemical	MESH:D002784
33685483	1418	1423	PINK1	Gene	65018
33685483	1479	1484	Abeta	Gene	351
33685483	1555	1566	cholesterol	Chemical	MESH:D002784
33685483	1589	1600	glutathione	Chemical	MESH:D005978
33685483	1602	1605	GSH	Chemical	MESH:D005978
33685483	1677	1680	ROS	Chemical	-
33685483	1720	1731	cholesterol	Chemical	MESH:D002784
33685483	1768	1773	PSEN1	Gene	19164
33685483	1774	1780	SREBF2	Gene	20788
33685483	1781	1785	mice	Species	10090
33685483	1910	1920	optineurin	Gene	10133
33685483	1922	1926	OPTN	Gene	71648
33685483	1939	1950	cholesterol	Chemical	MESH:D002784
33685483	1978	1983	PSEN1	Gene	19164
33685483	1984	1990	SREBF2	Gene	20788
33685483	1991	1995	mice	Species	10090
33685483	2038	2042	OPTN	Gene	10133
33685483	2048	2053	HDAC6	Gene	15185
33685483	2122	2137	GSH ethyl ester	Chemical	-
33685483	2139	2144	GSHee	Chemical	-
33685483	2211	2213	AD	Disease	MESH:D000544
33685483	2248	2252	OPTN	Gene	71648
33685483	2322	2333	cholesterol	Chemical	MESH:D002784
33685483	2349	2351	AD	Disease	MESH:D000544
33685483	2429	2440	cholesterol	Chemical	MESH:D002784
33685483	2517	2528	cholesterol	Chemical	MESH:D002784
33685483	2577	2580	ROS	Chemical	-
33685483	2618	2620	AD	Disease	MESH:D000544
33685483	Association	MESH:D002784	19164
33685483	Association	MESH:D002784	15185
33685483	Association	MESH:D000544	71648
33685483	Negative_Correlation	MESH:D002784	MESH:D005978
33685483	Positive_Correlation	MESH:D002784	351
33685483	Association	5071	65018
33685483	Negative_Correlation	MESH:D002784	71648
33685483	Negative_Correlation	MESH:D005978	65018
33685483	Association	19164	20788
33685483	Positive_Correlation	MESH:D002784	65018
33685483	Association	MESH:D000544	20788
33685483	Association	MESH:D002784	MESH:D000544
33685483	Negative_Correlation	MESH:D002784	10133
33685483	Association	10133	15185

